1. Research and Development is at the core of
Leucine Rich Bio. We leverage deep
understanding of disease biology and
bioinformatics to embark upon novel in‐
house solutions to drug discovery. Our
current efforts are to utilize system biology
and big data approaches to uncover novel
targets for different diseases. We are also
looking for partners with complimentary
capabilitiestotakeourmissionforward.
Research & Development
Please write to us for more information
or for collaboration at
Interested in our products and services?
Leucine Rich Bio is actively seeking alliance
partners to distribute and promote its
products in South East Asia, Australia, Europe,
MiddleEastandtheAmericas.
Pleasegetintouchwithusat:
partners@leucinerichbio.com
rnd@leucinerichbio.com
Alliance & Partners
Leucine Rich Bio Private Limited
679/57, 30th Cross Jayanagar 4th T block
Bangalore – 560 041
info@leucinerichbio.com www.leucinerichbio.com
Genome Data Analysis
Discover | Decipher | Deliver
Our India Partner
www.leucinerichbio.com
info@leucinerichbio.com
+91 973 909 9468
+91 973 909 9468

2. Leucine Rich Bio’s area of focus is in Human Genome Interpretation,
especially for clinical and research use. We use advances in the area of
Computer Science, Information Science, Data Management, Statistics and
Systems Biology to solve complex problems in Genomics. We envision using
cutting edge big data approaches along with machine learning algorithms to
delve deeper into the understanding of the human genome and develop
novelsolutionstodrugdiscovery.
Company
02
LeucineRichBioPrivateLimited
www.leucinerichbio.com
• Proprietary Analysis Platform
• Multilayered Encrypted Privacy
• Quick Turn Around Time
• Affordable Pricing
For Research
+91 973 909 9468 info@leucinerichbio.com
Small RNA Analysis
Transcriptome Analysis
NGS data can lead to novel
discoveries.If you have performed
an NGS ex‐periment and want to
analyze the data to interpret or
reinterpret the genome and the
transcriptome then Leucine Rich
Bio’s proprietary pipelines can
help achieve your goals in a fast,
accurate and affordable manner.
Genome Analysis
Leucine Rich Bio provides in
depth Genome Analysis. We
provide accurate reports on
variant calling, and de novo
mutations. An automated
analysis pipeline provides high‐
powered genome analysis with
support for the IGV‐ and USCS
browsers as well as VarSifter.
Transcriptome Sequencing
analyses provides information
to detect novel transcribed
regions, splice event, additional
promoters, exons, and 3’
untranscribed regions. We also
help analyse the impact of
transcription on key signalling
pathways.
Leucine Rich Bio’s small RNA
sequencing analysis platform
utilizes powerful algorithms to
study the subset of RNA in
various organisms. We
specialise in discovering novel
miRNA and their potential
targets.

3. Our Technology
04
LeucineRichBioPrivateLimited
Advanced Genome Interpretation Suite
+91 973 909 9468 info@leucinerichbio.comwww.leucinerichbio.com
AGIS (Advanced Genome Interpretation Suite) is a Clinical Data
Analysis Platform for Analyzing and Interpreting Clinically Relevant
Sequence information from Human Genomes. AGIS uses powerful
algorithms to report precise Disease Causing Mutations.
Our proprietary platform AGIS based customized report translates
complex genomic data into clinically relevant and actionable biological
information.
At Leucine Rich Bio we help clinicians appreciate the value of
Personalized Medicine. AGIS’ powerful algorithms eliminate the bottle
neck in data analysis and interpretation of Genomic Data for
Healthcare providers. AGIS provides end to end data Interpretation
Solutions.
AGIS interface and algorithms are designed to provide information in a
fast yet accurate manner. AGIS outputs physician ready reports. AGIS has
undergone extensive in‐silico validation testing for its accuracy and
consistency (sensitivity 98%; specificity 96%).
Our in house manually curated (Human Genome VariationLRB‐HGVD
Database) provides functional information, mutation impact on
disease, drug response and variant impact on protein structure and
function. LRB‐HGVD is tailored to provide variant functional
information to AGIS.
AGIS uses an advanced intuitive ranking system to identify clinically
relevant variants. The proprietary ranking algorithm is highly effcient to
identify complex range of variants including de novo variations,
idiopathic disease variants, novel disease causative variants, rare
variants and common phenotypic variants.
Clinical Reports
Cloud Computing Accurate Analysis Tested & Validated Data Security

4. • Mutation Analysis for Cancer
• Orphan Disease Diagnosis
• Discover Novel Mutations
• Better Therapy Management
06
LeucineRichBioPrivateLimited
www.leucinerichbio.com
For Clinics
The Management Team
The Management Team has over 30 years of cumulative experience in
Systems Biology, Bioinformatics, Genomics,
Molecular Biology and Drug Discovery.
Kumar Sankaran – Founder & Director
– Co‐Founder & DirectorPrabhath Manjappa
–Director Business Development & InnovationDr.Debojyoti Dhar
+91 973 909 9468 info@leucinerichbio.com
In this era of personalized/precision
medicine, fast and accurate diagnosis is
key for proper prognosis and treatment
of diseases. We at Leucine Rich Bio
understand the relevance and scope of NGS
data that can deliver meaningful and
actionable information to diagnostic
companiesandclinicians.